Epidemiology and treatment of psoriasis: a Brazilian perspective

Gleison V Duarte,1 Larissa Porto-Silva,2 Maria de Fátima Paim de Oliveira1 1Dermatology Department, Federal University of Bahia, Salvador, 2Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brazil Abstract: Psoriasis is a chronic immune-mediated systemic dis...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Duarte GV, Porto-Silva L, Oliveira MdeFP
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Dermatology RL1-803
Acceso en línea:	https://doaj.org/article/ef1be92f0b0c4a46905ffc76e59edf23
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ef1be92f0b0c4a46905ffc76e59edf23
record_format	dspace
spelling	oai:doaj.org-article:ef1be92f0b0c4a46905ffc76e59edf232021-12-02T01:32:04ZEpidemiology and treatment of psoriasis: a Brazilian perspective2230-326Xhttps://doaj.org/article/ef1be92f0b0c4a46905ffc76e59edf232015-04-01T00:00:00Zhttp://www.dovepress.com/epidemiology-and-treatment-of-psoriasis-a-brazilian-perspective-peer-reviewed-article-PTThttps://doaj.org/toc/2230-326XGleison V Duarte,1 Larissa Porto-Silva,2 Maria de Fátima Paim de Oliveira1 1Dermatology Department, Federal University of Bahia, Salvador, 2Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brazil Abstract: Psoriasis is a chronic immune-mediated systemic disease that is influenced by genetic and environmental factors, is associated with comorbidities, and has a negative impact on the quality of life of affected individuals. The prevalence of psoriasis varies among different ethnic groups, but this topic has not been studied in Brazil to date. In this review, we evaluate the epidemiology and treatment of psoriasis from a Brazilian perspective. We focused on studies that involved Brazilian subjects. The prevalence of psoriasis in Brazil is estimated to be 2.5%, but no population study has been performed previously. Environmental factors, such as tropical climate, in association with genetic factors, such as miscegenation, may exert a beneficial impact on the course and frequency of psoriasis in Brazil. A number of studies have advanced our understanding of the cardiovascular, ophthalmic, and oral comorbidities that are associated with psoriasis. Concerns about biological therapy, such as endemic leprosy, human T-cell lymphotropic virus (HTLV), and tuberculosis infections, are discussed. The nonavailability of treatment options for psoriasis in the public health system contradicts the Brazilian Society of Dermatology guidelines, stimulating the judicialization of access to medicines in psoriasis care. Keywords: psoriasis, epidemiology, comorbidities, health services accessibility, health care disparities, insurance, health care costsDuarte GVPorto-Silva LOliveira MdeFPDove Medical PressarticleDermatologyRL1-803ENPsoriasis: Targets and Therapy, Vol 2015, Iss default, Pp 55-64 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Dermatology RL1-803
spellingShingle	Dermatology RL1-803 Duarte GV Porto-Silva L Oliveira MdeFP Epidemiology and treatment of psoriasis: a Brazilian perspective
description	Gleison V Duarte,1 Larissa Porto-Silva,2 Maria de Fátima Paim de Oliveira1 1Dermatology Department, Federal University of Bahia, Salvador, 2Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brazil Abstract: Psoriasis is a chronic immune-mediated systemic disease that is influenced by genetic and environmental factors, is associated with comorbidities, and has a negative impact on the quality of life of affected individuals. The prevalence of psoriasis varies among different ethnic groups, but this topic has not been studied in Brazil to date. In this review, we evaluate the epidemiology and treatment of psoriasis from a Brazilian perspective. We focused on studies that involved Brazilian subjects. The prevalence of psoriasis in Brazil is estimated to be 2.5%, but no population study has been performed previously. Environmental factors, such as tropical climate, in association with genetic factors, such as miscegenation, may exert a beneficial impact on the course and frequency of psoriasis in Brazil. A number of studies have advanced our understanding of the cardiovascular, ophthalmic, and oral comorbidities that are associated with psoriasis. Concerns about biological therapy, such as endemic leprosy, human T-cell lymphotropic virus (HTLV), and tuberculosis infections, are discussed. The nonavailability of treatment options for psoriasis in the public health system contradicts the Brazilian Society of Dermatology guidelines, stimulating the judicialization of access to medicines in psoriasis care. Keywords: psoriasis, epidemiology, comorbidities, health services accessibility, health care disparities, insurance, health care costs
format	article
author	Duarte GV Porto-Silva L Oliveira MdeFP
author_facet	Duarte GV Porto-Silva L Oliveira MdeFP
author_sort	Duarte GV
title	Epidemiology and treatment of psoriasis: a Brazilian perspective
title_short	Epidemiology and treatment of psoriasis: a Brazilian perspective
title_full	Epidemiology and treatment of psoriasis: a Brazilian perspective
title_fullStr	Epidemiology and treatment of psoriasis: a Brazilian perspective
title_full_unstemmed	Epidemiology and treatment of psoriasis: a Brazilian perspective
title_sort	epidemiology and treatment of psoriasis: a brazilian perspective
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/ef1be92f0b0c4a46905ffc76e59edf23
work_keys_str_mv	AT duartegv epidemiologyandtreatmentofpsoriasisabrazilianperspective AT portosilval epidemiologyandtreatmentofpsoriasisabrazilianperspective AT oliveiramdefp epidemiologyandtreatmentofpsoriasisabrazilianperspective
_version_	1718403049867706368

Epidemiology and treatment of psoriasis: a Brazilian perspective

Ejemplares similares